reports
- Emmanuel Matot
- Emmanuel Matot
Half-year report on the liquidity contract as of December 31, 2024
Half-year report on the liquidity contract as of December 31, 2024 Half-year report on the liquidity contract as of December 31, 2024Issy-les-Moulineaux, France – January 9, 2025 Regulated information Half-year report on Pluxee N.V.’s liquidity contract as of December 31, 2024 Pursuant to the liquidity contract entered into by Pluxee N.V. with BNP Paribas, the following assets appeared on the liquidity account as of December 31, 2024: 200,439 Pluxee N.V. ordinary shares€5,878,911 During the period from July 1, 2024 to December 31, 2024, the following transactions were p...
Bilan semestriel du contrat de liquidité au 31 décembre 2024
Bilan semestriel du contrat de liquidité au 31 décembre 2024 Bilan semestriel du contrat de liquidité au 31 décembre 2024Issy-les-Moulineaux, France – 9 janvier 2025 Information réglementée Bilan semestriel du contrat de liquidité de Pluxee N.V. au 31 décembre 2024 Au titre du contrat de liquidité confié par la société Pluxee N.V. à BNP Paribas, en date de dénouement du 31 décembre 2024, les moyens suivants figuraient au compte de liquidité : 200 439 actions ordinaires Pluxee N.V.5 878 911 € Durant la période du 1er juillet 2024 au 31 décembre 2024, il a été négocié un total de...
- Jacob Mekhael
Galapagos Conference call feedback: Business split creates freedom for...
Yesterday, Galapagos announced that the company will be split into 2 public entities being i) Galapagos (GLPG 2.0), which will solely focus on the cell therapy program while gaining freedom from the Gilead agreement, and ii) SpinCo, with new management and € 2.45b to develop a new pipeline using BD in collaboration with Gilead. Below we provide our key takeaways from the conference call and our 1-1 interaction with management.
- Baptiste Salaville
- Emira Sagaama
- Emmanuel Matot
- Jerôme Bodin
- Baptiste Salaville
- Bruno Cavalier
- Emira Sagaama
- Emmanuel Matot
- Jerôme Bodin
- Christophe Chaput
- Sinan Doganli
- Johanna Jourdain
- Damien Choplain
- Martial Descoutures
- Damien Choplain
- Martial Descoutures
- Arnaud Autier
- Pierre Tegner
- Arnaud Autier
- Pierre Tegner
- Christophe Chaput
- Jacob Mekhael
Galapagos Separating into 2 public entities
Galapagos announced a planned separation into two entities: a newly to be formed company (SpinCo), which would focus on building a pipeline of innovative medicines through transformational transactions, and Galapagos, which would continue to advance its global cell therapy program. We believe this separation is a good step that will allow Galapagos to have a more focussed strategy slowly based on cell therapy/oncology, while freeing the company from the options agreement with Gilead, and this ne...
- Guy Sips
- Jacob Mekhael
- Lynn Hautekeete
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.